Introduction
Limbic encephalitis associated with anti-voltage-gated potassium channel complex (VGKCC) antibodies is an autoimmune, usually non-paraneoplastic form of encephalitis that usually responds to immunotherapy. Early initiation of immunotherapy has been shown to improve outcome. 1 The diagnosis of VGKCC encephalitis is often difficult to establish and autoantibody results can be delayed by up to two weeks. Other investigations, particularly cerebral 18F-fluoro-2-deoxy-dglucose positron emission tomography (FDG-PET) imaging, could be useful for early diagnosis. Striatal hypermetabolism and/or cortical hypometabolism have been observed on FDG-PET in patients with VGKCC encephalitis. We describe a clinical case of VGKCC encephalitis in which semi-quantitative analysis of cerebral FDG-PET revealed striatal hypermetabolism with normal cortical and cerebellar uptake prior to successful treatment with plasmapheresis.
Case report
A 69-year-old woman presented to the emergency room following a three-minute, witnessed episode of loss of awareness during which time she was dysarthric and appeared to hyperventilate. She had a number of similar episodes of unresponsiveness over the previous two months. Her family also reported progressive memory difficulties and a change in personality with the patient becoming more introverted and disinterested in family events over the prior two years. The patient was increasingly disoriented in time and uncharacteristically careless about personal hygiene and appearance. Past medical history was significant for paroxysmal atrial fibrillation, hypertension, hypercholesterolemia, hypothyroidism and a suspected transient ischaemic attack in 2011. She was treated with warfarin, rosuvastatin, bisoprolol and levothyroxine. She was an ex-smoker and consumed 10-15 units of alcohol per week.
Physical examination was unremarkable but cognitive deficits were noted on Montreal Cognitive Assessment (MoCA) with a score of 7/30. Initial routine investigations were unremarkable; however, blood testing revealed hyponatremia (127 mmol/l). Serum and urine biochemistry was consistent with a syndrome of inappropriate antidiuretic hormone (SIADH) secretion and hyponatremia responded to fluid restriction.
During admission a number of bilateral faciobrachial dystonic seizures 2 were noted. An electroencephalogram (EEG) showed posterior intermittent bilateral alpha activity with frequent runs of slowing maximal in the left temporo-parietal region. Typical faciobrachial seizures occurred during the recording. These were preceded by relative attenuation of activity bilaterally followed by rhythmical activity in the hemisphere corresponding to the side of the seizure. Magnetic resonance imaging (MRI) of the brain with gadolinium revealed T2 and fluid-attenuated inversion recovery (FLAIR) hyperintensities in the subcortical and deep white matter of both cerebral hemispheres. These non-specific findings most likely reflected chronic microvascular ischaemic changes. Cerebrospinal fluid (CSF) cell count and protein levels were normal. Given the clinical suspicion of limbic encephalitis, VGKCC antibodies were ordered. The patient was treated with levetiracetam (1500 mg twice daily), intravenous methylprednisolone (1000 mg once daily for five days) and intravenous immunoglobulin (0.4 g/kg for five days) without significant clinical improvement.
An FDG-PET brain scan performed two weeks after admission revealed marked hypermetabolism in the striatum with reduced uptake in the cortex and cerebellum on qualitative inspection (Figure 1(a) ). Semi-quantitative analysis was performed using maximum standardised uptake values (SUVmax) calculated at specific regions of interest (ROIs) measuring 107.5 mm 2 over the heads of the caudate nuclei, parieto-occipital cortices and cerebellar hemispheres (Figure 1(b) Of note, VGKCC antibodies requested prior to treatment returned 3439 pmol/l in serum and 96 pmol/ l in CSF (positive > 88 pmol/l). A clinical response was noted following 10 sessions of plasmapheresis. Over the next three weeks, the patient became more alert and oriented. Her concentration and cognitive function improved (MoCA score of 22/30). Sodium levels normalised. A paraneoplastic screen including whole-body FDG-PET was normal. Six weeks after initial presentation, repeat VGKCC antibody testing was negative in serum (17 pmol/l). A repeat FDG-PET brain scan performed three months after her initial presentation showed normalisation of striatal hypermetabolism (right caudate nucleus SUVmax 8.2 AE 0.7 and left caudate nucleus SUVmax 8.1 AE 0.7) and stable normal cortical (right SUVmax 6.8 AE 0.5 and left SUVmax 6.3 AE 0.4) and cerebellar uptake (right SUVmax 5.9 AE 0.4 and left SUVmax 6.2 AE 0.4) (Figures 2(a) and (b) ). Ratios comparing uptake at the caudate nuclei to parieto-occipital cortex reduced to 1.4 bilaterally. The parieto-occipital to cerebellum uptake ratio was stable at 1.15 and 1.02 on the right and left side, respectively. SUVmax values for the parieto-occipital cortices and cerebellum were within normal limits 3 on both FDG-PET scans and the difference in sequential cortical SUVmax values was within the expected variance observed between investigations. 4 In contrast, glucose metabolism at the caudate nuclei reduced by almost 45% between investigations. This was more than could be explained by variance alone and suggested a true elevation of striatal metabolism during active VGKCC encephalitis with normalisation of striatal metabolism following treatment.
Discussion
This patient presented with typical features of VGKCC encephalitis: faciobrachial dystonic seizures, personality changes, progressive cognitive decline and hyponatremia. 1, 2 The cerebral FDG-PET imaging in this case revealed striatal hypermetabolism by both qualitative and semi-quantitative analysis, with normal uptake in the cortex and cerebellum when analysed semiquantitatively (Figure 1(a) and (b) ).
The observation of striatal hypermetabolism in VGKCC encephalitis has been described previously 2,5-9 and may represent a preferential targeting of striatal antigens by VGKCC antibodies, particularly in the context of clinical faciobrachial dystonic seizures. 2 Faciobrachial dystonic seizures appear to be closely associated with the leucine-rich glioma inactivated-1 (LGI1) protein target of VGKCC antibodies. LGI1 protein is most strongly expressed in the hippocampus 10 without definite preponderance to the striata. Testing for the LGI1 subtype was not available when the patient was symptomatic.
In most of these cases relative cortical hypometabolism is also reported with various proposed mechanisms. [5] [6] [7] [8] Most of these descriptions were based on qualitative analysis of cerebral FDG-PET scans. In our case, qualitatively this also appeared to be the case. The qualitative appearances are due to autowindowing of the image with reference to the area of greatest FDG uptake (striatum). However, when semiquantitative analysis was performed, cortical metabolism was normal on both FDG-PET scans and striatal hypermetabolism was observed during the symptomatic phase. We therefore believe some reports on cortical FDG-PET abnormalities in VGKCC encephalitis may represent the relative change in cortical metabolism compared with striatal metabolism.
A recent study identified basal ganglia T1 hyperintensity as a clinically useful MRI biomarker of LGI1-related faciobrachial dystonic seizures. 11 It has been postulated that basal ganglia T1 hyperintensity on MRI 11 and striatal hypermetabolism on FDG-PET 2 are a consequence of faciobrachial dystonic seizures. However, the persistence of basal ganglia 6)) and stable normal cortical (right SUVmax 6.8 AE 0.5 (7) and left SUVmax 6.3 AE 0.4 (8)) and cerebellar uptake (right SUVmax 5.9 AE 0.4 and left SUVmax 6.2 AE 0.4).
hyperintensity following the resolution of seizures goes against this hypothesis. 11 Of those with basal ganglia hyperintensity on MRI, variable findings were observed on FDG-PET brain including, striatal hypermetabolism and cortical hypometabolism. Given that the MRI brain in this case was normal, it is unlikely that striatal hypermetabolism was secondary to inflammation, or indeed seizures. Striatal hypermetabolism has been in observed in other autoimmune conditions with associated movement disorders, including systemic lupus erythematosus, antiphospholipid syndrome and Sydenham chorea. 7 It has also been reported in the early stage of human immunodeficiency virus (HIV)dementia. 7 In addition to the qualitative analysis of cerebral FDG-PET images, a semi-quantitative analysis could reveal subtle but important changes in VGKCC encephalitis. For instance, we believe that the hypometabolic brain pattern reported in previous studies is a relative phenomenon and that when clinically suspected, the finding of striatal hypermetabolism on cerebral FDG-PET imaging can support a diagnosis of VGKCC encephalitis. This pattern could be specific for VGKCC encephalitis and might help distinguish the disorder from other forms of autoimmune encephalitides. 8 Prompt initiation of immunotherapy is recommended when there is a probable diagnosis of autoimmune encephalitis. 12 The results of cerebral FDG-PET, when available, might take much less time than results of VGKCC antibody titres. Further research is needed to validate the sensitivity and specificity of these findings.
